Article
Antibody-dependent cell-mediated cytotoxicity effector-enhanced EphA2 agonist monoclonal antibody demonstrates potent activity against human tumors.
Neoplasia (New York, N.Y.) - 1 Jun 2009
Bruckheimer Elizabeth M, Fazenbaker Christine A, Gallagher Sandra, Mulgrew Kathy, Fuhrmann Stacy, Coffman Karen T, Walsh William, Ready Shannon, Cook Kim, Damschroder Melissa, Kinch Michael, Kiener Peter A, Woods Rob, Gao Changshou, Dall'Acqua William, Wu Herren, Coats Steven
Abstract excerpt
EphA2 is a receptor tyrosine kinase that has been shown to be overexpressed in a variety of human tumor types. Previous studies demonstrated that agonist monoclonal antibodies targeting EphA2 induced the internalization and degradation of the receptor, thereby abolishing its oncogenic effects. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
